Using research from GlobalData’s Influencer platform, Pharmaceutical Technology has named ten of the most influential people in oncology on Twitter during Q2 2020.
Biggest influencers in oncology: The top ten in Q2 2020
1. Gilberto lopes (@GlopesMd)
Gilberto Lopes is an oncologist and the director for international programmes and associate director for global health at the University of Miami. He is also working as an associate professor at the university.
An expert in oncology, Dr. Lopes acts as an advisor to various governments and industries on health economics, cancer control and treatment in developing countries.
Twitter followers: 29,405
GlobalData influencer score: 100
Our study is out! #CCC19 @asco #asco20 #covid19ncancer @oncoalert @totalhealthconf @sylvestercancer is proud to be one of the five founding institutions – A big thank you to all participants. This was a grassroots, crowdsourcing effort nobody could do alone @thelancet pic.twitter.com/ZdmvycAQN7
— gilberto lopes (@GlopesMd) May 28, 2020
2. Mike Thompson (@mtmdphd)
Mike Thompson is the co-director of oncology precision medicine programme at Aurora Health Care, a not-for-profit healthcare system. A board certified hematologist and oncologist, he specialises in basic science, clinical trials and translational research.
Mike holds a PhD in pharmacogenetics and his areas of interest include cancer and hematologic cancers, while focussing on developing treatments such as early phase molecular biomarker.
Twitter followers: 20,247
GlobalData influencer score: 86
#COVID19 is shattering US cancer care: American oncologists are rushing to prioritise the patients at greatest risk, institute new protections & learn from their collective experiences [Apr 17, 2020] Nelson @bmj_latest https://t.co/mxoG3beUJr #COVID19nCancer #CCC19 HT @gary_lyman
— Mike Thompson, MD, PhD, FASCO (@mtmdphd) April 18, 2020
3. Mark Lewis (@marklewismd)
Mark Lewis is the director of gastrointestinal oncology at Intermountain Health Care, a not-for-profit healthcare provider. An M.D. in Medicine from the University of Utah, he specialises in patient safety, medical education, Health Information Technology (HIT) and Electronic Medical Record (EMR).
Dr. Lewis’ areas of interest include neuroendocrine tumours, young onset cancers, and hereditary cancer conditions.
Twitter followers: 33,591
GlobalData influencer score: 81
KEYNOTE-177! a new era for 1st-line immunotherapy in MSI-high/MMR-deficient metastatic colorectal cancer dawns. Pembro superior to chemo for PFS (median 16.5 mo vs 8.2 mo; HR 0.60; 95% CI, 0.45-0.80; P=0.0002)
— Mark Lewis (@marklewismd) May 28, 2020
4. Dee Sparacio (@womenofteal)
Dee Sparacio is the co-founder and co-moderator of gyncsm (gynaecologic cancer social media) community on Twitter. A cancer survivor herself, Dee has co-authored the book 100 Questions and Answers about Ovarian Cancer. She is an advocate member of the Rutger’s Cancer Institute of NJ Scientific Review Board.
Sparacio is also a public speaker who has presented at various conventions for ovarian cancer.
Twitter followers: 5,231
GlobalData influencer score: 79
— Dee Sparacio (@womenofteal) April 30, 2020
5. Minas Chrysopoulo (@drchrysopoulo)
Minas Chrysopoulo is a certified plastic surgeon specialising in breast reconstruction and cosmetic surgery. He is the president of PRMA Plastic Surgery, a medical group practice focussed on state-of-the-art breast reconstruction.
Minas is also the founder of the Breast Advocate app, which aims to help and support patients diagnosed with breast cancer and help them in surgery related decision making. His areas of interest include digital health and disruptive healthcare technologies.
Twitter followers: 43,319
GlobalData influencer score: 73
— Dr Minas Chrysopoulo (@drchrysopoulo) May 22, 2020
6. Matthew Katz (@subatomicdoc)
Matthew Katz is radiation oncologist affiliated with the Lowell General Hospital and Elliot Hospital. He is also a partner at the Radiation Oncology Associates, a cancer treatment centre and founder of Radiation Nation, a website providing information on radiation oncology. Katz has written several editorials, review articles and blogs for medical websites.
Twitter followers: 19,577
GlobalData influencer score: 69
— Matthew Katz, MD (@subatomicdoc) April 4, 2020
7. Christina Lizaso (@btrfly)
Christina Lizaso is a community engagement professional, who works as patient advisor at Clara Health, an online platform offering access to breakthrough clinical trials. She is also the co-founder of gyncsm community on Twitter.
An expert in healthcare digital community building, Christina’s areas of expertise include editing publications, working with volunteer committees and drafting policies and procedures.
Twitter followers: 6,138
GlobalData influencer score: 68
— Christina Lizaso (@btrfly12) May 14, 2020
8. Stephen V Liu (@StephenVLiu)
Dr. Stephen V Liu is the director of Thoracic Oncology and Developmental Therapeutics at the cancer center of Georgetown University. He is also an associate professor of medicine at the university and an expert in the fields of developmental therapeutics, lung cancer, oncology and mesothelioma.
Dr. Liu’s research is focused on developing novel therapeutic agents and unique combinations to treat lung cancer.
Twitter followers: 4,961
GlobalData influencer score: 67
#OncoAlert Brigatinib receives approval from the @US_FDA for the first line treatment of #ALK positive #NSCLC. Based on the phase III ALTA-1L trial which compared brigatinib to crizotinib and showed PFS HR 0.49, ORR 74% and intracranial RR 78%. #LCSMhttps://t.co/P7K7ftBAhQ
— Stephen V Liu (@StephenVLiu) May 22, 2020
9. Kathleen D. Hoffman (@drkdhoffman)
Kathleen D. Hoffman is the senior health researcher and writer at Inspire, a healthcare social network. A communication expert and serial connector, she specialises in social science research, behaviour change and attitude development. Her work supports companies and providers to increase their influence on social media.
Kathleen is also a researcher and educator who decodes complex scientific, clinical and medical language for the general audience.
Twitter followers: 15,801
GlobalData influencer score: 66
A recent study conducted in Germany assessed acute and post traumatic stress disorders in women diagnosed with breast cancer before treatment, after treatment and one year after diagnosis. 82% of the women had symptoms of PTSD https://t.co/AohFMdx1y3 cancer pic.twitter.com/dPWWWxW1ut
— Kathleen D. Hoffman (@drkdhoffman) April 18, 2020
10. Nathan A. Pennell (@n8pennell)
Nathan A. Pennell is the director of lung cancer programme at Cleveland Clinic and deputy vice chair at Taussig Cancer Institute. He has an M.D. in Medicine from the University of Florida and is also a consultant editor for a leading oncology journal.
Widely active in patient and graduate medical education, Dr. Pennel is an expert in translational research, clinical trials, patient care and thoracic malignancies.
Twitter followers: 9,553
GlobalData influencer score: 65
As of today we officially have to test for EGFR+ALK+ROS1+BRAF+NTRK+RET+MET (plus PDL1), so absolutely positively no way to do this reliably without universal NGS testing at diagnosis for every nonsquamous NSCLC patient. Together this is about 30% of lung adenocarcinoma! #LCSM https://t.co/zw9CJXMnsy
— Nathan A. Pennell MD, PhD, FASCO (@n8pennell) May 9, 2020